Mechanisms and Regulation of Human Translesion DNA Polymerases
Mechanisms and Regulation of Human Translesion DNA Polymerases
批准号:
8640444
负责人:
Richard T Pomerantz
金额:
$23.41万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2016-03-31
关键词:
Advisory CommitteesAffectBindingBiochemicalBiological AssayBypassCancer BiologyCellsClinicalCollaborationsColorectal CancerCommittee MembersDNADNA DamageDNA-Directed DNA PolymeraseDouble Strand Break RepairEnzymesExhibitsGenetic RecombinationGenomic InstabilityGoalsHumanIn VitroInduced MutationInvestigationLeadLesionMalignant NeoplasmsMediatingMentorsMolecularMolecular MachinesMono-SMutagenesisMutagensMutationOutcomePathway interactionsPolymeraseProcessProliferatingRadiationRadiation therapyRecruitment ActivityRegulationResearchResistanceSiteSpecificityStagingStructureTherapeuticTherapeutic AgentsTopoisomeraseWorkX-Ray CrystallographyYeastsbasecancer cellcancer riskcancer therapychemotherapyenzyme modelhigh throughput screeninginhibitor/antagonistinsightmalignant breast neoplasmneoplastic cellnovelnovel therapeuticsoverexpressionrepairedsmall moleculetumortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Replicative DNA polymerases (pols) copy chromosomal DNA, but stall at lesions caused by DNA damaging
agents. Specialized translesion pols have therefore evolved to promote replication past DNA damage thus
allowing cells to proliferate in the face of genotoxic agents. Translesion pols are, however, error-prone and
thus induce mutations which can lead to tumorigenesis.
Pol is a newly discovered translesion pol which is involved in double-strand break (DSB) repair.
Overexpression of pol causes genome instability and high levels of the pol are found in breast and colorectal
cancers, which corresponds to a poor clinical outcome. Reducing the expression level of pol , however,
sensitizes various tumor cells to radiation. Inhibitors of pol are therefore likely to increase the efficacy and
specificity of radiation therapy. Specific Aim 1 will identify and characterize inhibitors of pol for
potential cancer therapeutics.
Since translesion pols are error-prone, stringent regulation of these enzymes is necessary for minimizing
mutagenesis and cancer risk. How translesion pols are regulated and recruited to sites of DNA damage is
poorly understood. Specific Aim 2 will investigate the regulation and recruitment of translesion pol
during translesion synthesis.
In addition to bypassing lesions, pol replicates DNA recombination intermediates called D-loops which are
formed during the repair of DSBs. How pol performs this important function is poorly understood. Specific
Aim 3 will investigate the mechanism by which pol extends D-loop recombination intermediates.
Studies perfomed during the mentored stage (Aim 1) will use high-throughput screening and X-ray
crystallography to identify and characterize inhibitors of pol for potential applications in cancer therapeutics.
Research performed during the independent stage (Aims 2 and 3) will initially focus on the mechanisms and
regulation of human pol as a model enzyme. These studies will then be extended to pol which is implicated
in the same pathways as pol such as transleson synthesis and D-loop extension. The proposed research is
likely to provide significant insight into the molecular mechanisms of DNA damage tolerance and cancer
biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure Based Design of Pol-theta inhibitors
-
批准号:10323627
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2021
-
负责人:Richard T Pomerantz
-
依托单位:
Next-generation precision medicine for targeting recombination-deficient cancers
-
批准号:9909705
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of RNA-DNA repair
-
批准号:10336801
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
PolQ as a novel therapeutic target in AML
-
批准号:10545175
-
项目类别:
-
资助金额:$52.39万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of RNA-DNA repair
-
批准号:10385826
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of RNA-DNA repair
-
批准号:10594960
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
PolQ as a novel therapeutic target in AML
-
批准号:10322361
-
项目类别:
-
资助金额:$53.58万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10094002
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10377900
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10336827
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9109640
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Targeting BRCA Deficient Cells for Killing
-
批准号:9114099
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9276915
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:8939152
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9309021
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9751314
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:10322874
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8824838
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2013
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8643774
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2013
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8300404
-
项目类别:
-
资助金额:$12.27万
-
财政年份:2012
-
负责人:Richard T Pomerantz
-
依托单位:
海外基金